Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging
Zhenwei Gong
, Emir Tas
,
Shoshana Yakar
, Radhika Muzumdar
Research output
:
Contribution to journal
›
Article
›
peer-review
132
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Aging
100%
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Hepatic Lipid Metabolism
100%
Dysregulation
50%
Glucose Metabolism
50%
Obesity
25%
Non-modifiable Risk Factors
25%
Recent Advances
25%
Cirrhosis
25%
Adiponectin
25%
Steatohepatitis
25%
Insulin
25%
Insulin Resistance
25%
Physiological Changes
25%
Metabolic Syndrome
25%
Physiological Processes
25%
Lipid Metabolism
25%
Advanced Age
25%
Hepatic Lipid Accumulation
25%
Poor Clinical Outcomes
25%
Age-related Illnesses
25%
Linear Relationship
25%
Leptin
25%
Age-associated
25%
Fibroblast Growth Factor 21 (FGF21)
25%
Histological Changes
25%
Mitochondrial-derived Peptides
25%
Systemic Implications
25%
Resistance Risk
25%
Nolinear
25%
Metabolism Syndrome
25%
Glucose Metabolic
25%
Immunology and Microbiology
Lipid Metabolism
100%
Lipid Liver Level
100%
Non-Alcoholic Fatty Liver Disease
100%
Mediator
50%
Glucose Metabolism
50%
Steatohepatitis
25%
Mitochondrion
25%
Prevalence
25%
Insulin Resistance
25%
Lipid Storage
25%
Adiponectin
25%
Fibroblast Growth Factor 21
25%
Insulin
25%
Peptides
25%
Leptin
25%
Medicine and Dentistry
Nonalcoholic Fatty Liver
100%
Lipid Metabolism
100%
Glucose Metabolism
50%
Mediator
50%
Lipid Storage
25%
Prevalence
25%
Mitochondrion
25%
Liver Cirrhosis
25%
Metabolic Syndrome
25%
Insulin Resistance
25%
Adiponectin
25%
Leptin
25%
FGF21
25%
Steatohepatitis
25%
Diseases
25%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Prevalence
50%
Liver Cirrhosis
50%
Adiponectin
50%
Metabolic Syndrome X
50%
Insulin Resistance
50%
Fibroblast Growth Factor 21
50%
Leptin
50%
Diseases
50%
Biochemistry, Genetics and Molecular Biology
Lipid Liver Level
100%
Lipid Metabolism
100%
Glucose Metabolism
50%
Mediator
50%
Lipid Storage
25%
Mitochondrion
25%
Prevalence
25%
Insulin Resistance
25%
FGF21
25%
Adiponectin
25%
Leptin
25%